EVP, CFO of AMAG Pharmaceuticals Inc. (AMAG, Financial) David Arkowitz sells 2,705 shares of AMAG on 02/24/2011 at an average price of $17.07 a share.
Amag Pharmaceuticals Inc. has a market cap of $386.42 million; its shares were traded at around $18.3 with and P/S ratio of 22.5. Amag Pharmaceuticals Inc. had an annual average earning growth of 91.6% over the past 5 years.
Hedge Fund Gurus that owns AMAG: Jim Simons of Renaissance Technologies LLC.
For the complete insider trading history of AMAG, click here.
Amag Pharmaceuticals Inc. has a market cap of $386.42 million; its shares were traded at around $18.3 with and P/S ratio of 22.5. Amag Pharmaceuticals Inc. had an annual average earning growth of 91.6% over the past 5 years.
Hedge Fund Gurus that owns AMAG: Jim Simons of Renaissance Technologies LLC.
Directors and Officers Recent Trades:
- Buy: Chief Medical Officer and EVP Lee F Md Phd Allen bought 39 shares of AMAG stock on 12/01/2010 at the average price of 13.34. Lee F Md Phd Allen owns at least 1,951 shares after this. The price of the stock has increased by 37.18% since.
- Buy: 10% Owner Capital Partners Gp Llc Adage bought 1,000,000 shares of AMAG stock on 11/01/2010 at the average price of 15.87. Capital Partners Gp Llc Adage owns at least 3,723,909 shares after this. The price of the stock has increased by 15.31% since.
For the complete insider trading history of AMAG, click here.
